NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity & Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Diabetes Therapy



Doxazosin useful in patients with type 2 diabetes and hypertension



May 31st, 2004

Doxazosin is clinically beneficial in patients with type 2 diabetes complicated by hypertension.

"This uncontrolled study investigated the effects of using the alpha(1)-blocker doxazosin (2 mg or 4 mg daily for 3 months) to treat 21 hypertensive patients with type 2 diabetes, including eight obese individuals (body mass index [BMI] {{>=}}25.0 kg/m2). A significant reduction in systolic and diastolic blood pressure, beginning after 1 month of treatment, was seen," scientists in Japan report.

"There was no significant change in BMI," said Toshihiko Inukai and colleagues at Dokkyo University. "Although there was no obvious improvement in...


Source: Obesity & Diabetes Week (2004-05-31)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login